Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial
Clinical trial NCT05315557 · UNKNOWN
Trial details
- NCT number
- NCT05315557
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-05
- Primary completion
- 2023-03-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.